BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 36372853)

  • 1. Proteomic characterization of post-translational modifications in drug discovery.
    Zhai LH; Chen KF; Hao BB; Tan MJ
    Acta Pharmacol Sin; 2022 Dec; 43(12):3112-3129. PubMed ID: 36372853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate and Functional Diversity of Protein Lysine Post-translational Modifications.
    Hao B; Chen K; Zhai L; Liu M; Liu B; Tan M
    Genomics Proteomics Bioinformatics; 2024 May; 22(1):. PubMed ID: 38862432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers.
    Zhu G; Jin L; Sun W; Wang S; Liu N
    Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188735. PubMed ID: 35577141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational modifications of proteins in cardiovascular diseases examined by proteomic approaches.
    Stastna M
    FEBS J; 2024 Mar; ():. PubMed ID: 38440918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding Post-Translational Modification Crosstalk With Proteomics.
    Leutert M; Entwisle SW; Villén J
    Mol Cell Proteomics; 2021; 20():100129. PubMed ID: 34339852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems-wide proteomic characterization of combinatorial post-translational modification patterns.
    Young NL; Plazas-Mayorca MD; Garcia BA
    Expert Rev Proteomics; 2010 Feb; 7(1):79-92. PubMed ID: 20121478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of nanomaterials in proteomics-driven precision medicine.
    Zhang Y; Yang H; Yu Y; Zhang Y
    Theranostics; 2022; 12(6):2674-2686. PubMed ID: 35401834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniques.
    Zhao Y; Jensen ON
    Proteomics; 2009 Oct; 9(20):4632-41. PubMed ID: 19743430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Methods Employed in Mass Spectrometric Analysis of Posttranslational Modifications (PTMs) and Protein-Protein Interactions (PPIs).
    Yakubu RR; Nieves E; Weiss LM
    Adv Exp Med Biol; 2019; 1140():169-198. PubMed ID: 31347048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution and functional cross-talk of protein post-translational modifications.
    Beltrao P; Bork P; Krogan NJ; van Noort V
    Mol Syst Biol; 2013; 9():714. PubMed ID: 24366814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis tools for post-translational modification: a post-translational modification database for analysis of proteins and metabolic pathways.
    Cruz ER; Nguyen H; Nguyen T; Wallace IS
    Plant J; 2019 Sep; 99(5):1003-1013. PubMed ID: 31034103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STRAP PTM: Software Tool for Rapid Annotation and Differential Comparison of Protein Post-Translational Modifications.
    Spencer JL; Bhatia VN; Whelan SA; Costello CE; McComb ME
    Curr Protoc Bioinformatics; 2013 Dec; 44(1322):13.22.1-36. PubMed ID: 25422678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insights into cancer drug resistance from a proteomics perspective.
    An Y; Zhou L; Huang Z; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2019 May; 16(5):413-429. PubMed ID: 30925852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing disease-associated changes in post-translational modifications by mass spectrometry.
    Thygesen C; Boll I; Finsen B; Modzel M; Larsen MR
    Expert Rev Proteomics; 2018 Mar; 15(3):245-258. PubMed ID: 29376447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-translational modifications of pancreatic fluid proteins collected via the endoscopic pancreatic function test (ePFT).
    Paulo JA; Kadiyala V; Brizard S; Banks PA; Steen H; Conwell DL
    J Proteomics; 2013 Oct; 92():216-27. PubMed ID: 23500127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranslational modifications in systems biology.
    Aggarwal S; Tolani P; Gupta S; Yadav AK
    Adv Protein Chem Struct Biol; 2021; 127():93-126. PubMed ID: 34340775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Post-Translational Modifications and Molecular Substrates in Glioma Identified by Bioinformatics.
    Rex DAB; Arun Kumar ST; Rai AB; Kotimoole CN; Modi PK; Prasad TSK
    OMICS; 2021 Jul; 25(7):463-473. PubMed ID: 34227895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
    Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
    OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, Quantification, and Site Localization of Protein Posttranslational Modifications via Mass Spectrometry-Based Proteomics.
    Ke M; Shen H; Wang L; Luo S; Lin L; Yang J; Tian R
    Adv Exp Med Biol; 2016; 919():345-382. PubMed ID: 27975226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current strategies and findings in clinically relevant post-translational modification-specific proteomics.
    Pagel O; Loroch S; Sickmann A; Zahedi RP
    Expert Rev Proteomics; 2015 Jun; 12(3):235-53. PubMed ID: 25955281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.